Xuemin Yuan

Xuemin Yuan

Auto-generated profile, based on publicly available information

Xuemin Yuan

Information Search Center, Gansu Institute of Science and Technology Information, Lanzhou, Gansu, 730000, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2020 in Journal of Dentistry
Verified
Journal Article
Closed access
YZYunxia Zhang
Yunxia Zhang
XYXuemin Yuan
Xuemin Yuan
YWYuyan Wu
Yuyan Wu
MPMinyu Pei
Minyu Pei
MYMan Yang
Man Yang
JWJing Wang
Jing Wang

6 July 2022 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
MYMan Yang
Man Yang
YPYunqing Pang
Yunqing Pang
MPMinyu Pei
Minyu Pei
YLYuanyuan Li
Yuanyuan Li
XYXuemin Yuan
Xuemin Yuan
JWJing Wang
Jing Wang
Background. The relationship between diabetes and periodontitis is bidirectional, and there is now consensus that periodontitis and diabetes are comorbid. There is a quest for a drug that can be used to treat both conditions simultaneously. This study evaluated the anti-inflammatory and osteoprotective effects of liraglutide (LIRA) on periodontitis in diabetic rats. Methods. Male Wistar rats ( ) were randomly divided into four groups: control group ( ), LIRA group ( ), diabetes-associated periodontitis+0.9% saline group (diabetic periodontitis (DP)+NaCl group, ), and diabetes-associated periodontitis+LIRA group (DP+LIRA group, ). LIRA treatment lasted for 4 weeks (300 μg/kg/d) after establishment of a rat model of DP. The expression of IL-6, TNF-α, and IL-1β was detected by enzyme-linked immunosorbent assay. The morphological changes of periodontal tissues were observed by hematoxylin–eosin staining. The absorption of alveolar bone and its ultrastructural changes were observed by histomorphometry and microcomputed tomography. The expression of receptor activator of NF-κB ligand (RANKL) and osteoprotegerin (OPG) in alveolar bone was detected by immunohistochemistry. The levels of Runx2 mRNA and ALP mRNA in the gingival epithelium were examined by quantitative real-time polymerase chain reaction. Results. LIRA decreased alveolar bone resorption, improved the microstructure of alveolar bone, and reduced periodontal inflammation and damage ( ). LIRA also reduced blood glucose level and inhibited the secretion of serum IL-6, TNF-α, and IL-1β ( ). In addition, after treatment with LIRA, the ratio of RANKL/OPG was reduced, and the expression levels of ALP mRNA and Runx2 mRNA were upregulated ( ). Conclusions. LIRA not only controls blood glucose level but also reduces inflammation and bone loss and enhances osteogenic differentiation in diabetes-associated periodontitis. Those indicate that LIRA may be used as a potential medicine for the adjunctive therapy of diabetes-periodontitis comorbidity.

22 September 2022
Verified
Book Chapter
Open access
PDF file
XYXuemin Yuan
Xuemin Yuan
SYShengju Yang
Shengju Yang
QZQian Zhen
Qian Zhen
ZZZhonglei Zhao
Zhonglei Zhao